by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
hree years later Daniel Kreitman still chokes up when he talks about what he saw, and how it changed him. Kreitman, an upholsterer by trade, had taken psilocybin, a hallucinogen derived from mushrooms, in a trial at Johns Hopkins University School of Medicine for...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
Patients unresponsive to conventional treatments benefit when treated with natural psychoactive compound, but researchers warn against self medication. Magic mushrooms may effectively “reset” the activity of key brain circuits known to play a role in depression, the...
by EmpathiCSubstanceS | May 2, 2018 | Cancer
Richard Cone was going to die, just like everybody else. But unlike most, he could foresee his moment of passing. It was coming in 2, maybe 3 more years—at least that’s what his oncologist said. Cone had just been diagnosed with metastatic prostate cancer. The burden...
by EmpathiCSubstanceS | May 1, 2018 | Anxiety, Bipolar Disorder
By R. Andrew Sewell With the current renaissance in psychedelic research, after a forty-year moratorium, undergraduates interested in the topic are increasingly starting to ask: How can I get involved? Unfortunately, psychedelics are still heavily stigmatized, and...
by EmpathiCSubstanceS | Apr 25, 2018 | Psychedelic Medicine
MDMA, the active ingredient in the drug Ecstasy, has been reviled as a menace and even a killer. Now some therapists claim it can help light the way out of a traumatic past. Sarah lived in a basement for a few weeks when she was a child. But in a way, she lived there...
